T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Broadcom
AVGO
|
$898M |
| 2 |
Danaher
DHR
|
$756M |
| 3 |
Intuit
INTU
|
$719M |
| 4 |
PTC
PTC
|
$567M |
| 5 |
Salesforce
CRM
|
$412M |
Top Sells
| 1 |
CrowdStrike
CRWD
|
$882M |
| 2 |
Spotify
SPOT
|
$761M |
| 3 |
KKR & Co
KKR
|
$607M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$556M |
| 5 |
Goldman Sachs
GS
|
$547M |
Sector Composition
| 1 | Technology | 24.77% |
| 2 | Healthcare | 20.33% |
| 3 | Industrials | 12.32% |
| 4 | Consumer Discretionary | 11.57% |
| 5 | Financials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Five Star Bancorp
FSBC
$702M
| $44.6M | 0.03% |
1,884,348
+124,863
| +7% | +$2.95M |
|
402
Avanos Medical
AVNS
$590M
| $44.2M | 0.03% |
2,217,793
+291,026
| +15% | +$5.8M |
|
403
Valmont Industries
VMI
$7.46B
| $44.1M | 0.03% |
160,689
-12,328
| -7% | -$3.38M |
|
404
Boot Barn
BOOT
$5.58B
| $44M | 0.03% |
341,453
+41,528
| +14% | +$5.35M |
|
405
Globant
GLOB
$2.78B
| $43.1M | 0.03% |
+241,897
| New | +$43.1M |
|
406
Immunovant
IMVT
$2.99B
| $42.9M | 0.03% |
+1,625,220
| New | +$42.9M |
|
407
Advantage Solutions
ADV
$567M
| $42.8M | 0.03% |
13,285,429
+378,970
| +3% | +$1.22M |
|
408
Merus
MRUS
$5.1B
| $42.6M | 0.03% |
720,676
-8,339
| -1% | -$493K |
|
409
nCino
NCNO
$3.52B
| $42.5M | 0.03% |
1,352,465
+12,081
| +0.9% | +$380K |
|
410
Progyny
PGNY
$1.94B
| $42.2M | 0.03% |
+1,474,045
| New | +$42.2M |
|
411
10x Genomics
TXG
$1.74B
| $42.1M | 0.03% |
2,162,979
-41,451
| -2% | -$806K |
|
412
Pennant Group
PNTG
$840M
| $41.9M | 0.03% |
1,805,090
-864,993
| -32% | -$20.1M |
|
413
Coastal Financial
CCB
$1.66B
| $41.6M | 0.03% |
901,771
+31,490
| +4% | +$1.45M |
|
414
Pool Corp
POOL
$12.4B
| $41.6M | 0.03% |
135,269
+38,283
| +39% | +$11.8M |
|
415
Akero Therapeutics
AKRO
$3.58B
| $41.5M | 0.03% |
1,767,243
+665,194
| +60% | +$15.6M |
|
416
Urban Outfitters
URBN
$6.35B
| $41.3M | 0.03% |
1,007,132
+12,086
| +1% | +$496K |
|
417
CACI
CACI
$10.4B
| $41.3M | 0.03% |
+96,083
| New | +$41.3M |
|
418
Camden Property Trust
CPT
$11.9B
| $41.3M | 0.03% |
378,435
-33,839
| -8% | -$3.69M |
|
419
Abercrombie & Fitch
ANF
$4.49B
| $41.1M | 0.03% |
231,292
+34,464
| +18% | +$6.13M |
|
420
Tango Therapeutics
TNGX
$772M
| $40.8M | 0.03% |
4,755,979
+434,428
| +10% | +$3.73M |
|
421
Savers
SVV
$1.96B
| $40.6M | 0.03% |
3,316,342
+771,144
| +30% | +$9.44M |
|
422
Packaging Corp of America
PKG
$19.8B
| $40.4M | 0.03% |
221,151
-23,243
| -10% | -$4.24M |
|
423
Vulcan Materials
VMC
$39B
| $40M | 0.03% |
160,814
-113,018
| -41% | -$28.1M |
|
424
Atmos Energy
ATO
$26.7B
| $40M | 0.03% |
342,747
-116,786
| -25% | -$13.6M |
|
425
Vimeo
VMEO
$734M
| $38.7M | 0.02% |
10,369,704
-488,265
| -4% | -$1.82M |
|